Berman Capital Advisors’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1K Buy
2
+1
+100% +$854 ﹤0.01% 1787
2021
Q2
$1K Buy
+1
New +$876 ﹤0.01% 1681

Other funds holding AGL

Berman Capital Advisors's AGL Position: Q3 2021 in Review

Berman Capital Advisors increased its Agilon Health (AGL) stake by 100% in Q3 2021, buying an estimated $854 and bringing the position to 2 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1787.

Berman Capital Advisors first reported a position in AGL in Q2 2021 and has held it in 2 quarters since. 102 funds tracked by Wall St. Rank hold AGL as of Q3 2021.

  • Berman Capital Advisors held 2 shares of Agilon Health worth $1K as of Q3 2021.
  • Berman Capital Advisors bought 1 Agilon Health share in Q3 2021, an estimated $854.
  • Agilon Health made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1787 holding.
  • Berman Capital Advisors first reported a position in Agilon Health in Q2 2021 and has held it in 2 quarters since.
  • 102 funds tracked by Wall St. Rank held Agilon Health as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.